As per the research report titled ‘Asia Pacific Vascular Graft Market Forecast 2027 By Raw Material, By Application, By End-use, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, Asia Pacific vascular graft industry is predicted to garner a significant growth rate through 2027.

The rising prevalence of chronic ailments like diabetes and cardiovascular conditions in the region, various technological developments, and the growing elderly population are the major drivers leading to the expansion of Asia Pacific vascular graft market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4037686/  

Also, lowering death rate with longer lifespan is making individuals more prone to diseases, which along with increasing cases of kidney failures are bolstering the demand for vascular grafts.

On the other hand, the lack of qualified professionals and experts in emerging countries, and concerns regarding the infections caused by vascular graft are stifling the industry growth.

The bifurcation of the market concerning the application spectrum includes endovascular aneurysm repair (abdominal aortic aneurysms repair, thoracic aortic aneurysm repair), hemodialysis access, and peripheral vascular repair. As mentioned in the report, peripheral vascular repair segment accounted for USD 121.2 million in 2020 and is expected to grow steadily through 2027. The main reasons for growth are lower risk of complications during the treatment, and increasing cases of peripheral
arterial diseases.

Based on raw materials, Asia Pacific vascular graft market is categorized into biosynthetic grafts, EPTFE grafts, polyester grafts, and polyurethane grafts. Among these, polyester segment is projected to register 7.5% CAGR through 2027, owing to the high success rate of this material which provides a preventative biological seal to avoid infections, and the consistent technological development to make the material more suitable for human use. The material is highly compatible with human blood, durable, and has superior tensile strength.

Analyzing the market by end-use, the segmentation consists of ambulatory surgical centers, hospitals, and others. 

Observing the regional scope, Japan vascular graft industry share is expected to record a y-o-y growth rate of 7% through 2027, owing to growing elderly population, and a surge in the number of age-related diseases, eventually creating a huge demand for vascular grafts for severe disease treatment in the nation.

The top companies in Asia Pacific vascular graft marketplace include CryoLife, Inc., W.L. Gore & Associates, Inc., Medtronic plc, Getinge Group, B. Braun Melsungen AG, Becton Dickinson and Company, Cook Medical, LeMaitre Vascular, Inc., Terumo Corporation, and Endologix LLC.